资讯

Zacks Investment Research on MSN5 天
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?
ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...
TMCnet6 天
Inventprise Announces Breakthrough in COVID-19 Conjugate Vaccine Study Published in Vaccine ...
The 18-month study, initiated in 2022 and completed in late 2023, leveraged Inventprise’s proprietary linker protein conjugation technology platform. This advanced technology is designed to enhance ...